A federal judge in New Jersey has issued a dressing down to lawyers for Torrent Pharmaceuticals for wrongly designating discovery materials as confidential in the Valsartan multidistrict litigation.
Torrent’s lawyers sought confidential status for “routine business communications” produced in discovery, but it is not entitled to such protection “merely because a document may be harmful, uncomfortable or embarrassing,” U.S. Magistrate Judge Joel Schneider ruled Friday in the Valsartan MDL.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]